Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Identifying warning signs of poor retirement planning is essential for financial health. Learn how to act now for a more secure retirement.
15,085 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
China imposes export bans on 10 U.S. defense-related companies in a retaliation move as Washington tightens defense c...
Two high-profile banks ease their return-to-office stance for World Cup match days. The temporary shift aims to reduc...
New cost tallies show the true price of the Iran conflict to U.S. taxpayers near $200 billion, far above early Pentag...
The INDS ETF blends self-storage and warehouse assets to offer a roughly 3.5% yield, presenting a mixed exposure that...
Glenn Kelman has joined Greylock Partners as an executive in residence, months after stepping down from Redfin and fo...
JPMorgan Chase just paired a 10% dividend hike with a $50 billion buyback after clearing the Fed's stress test. Here'...
Hydrogen stocks have teased a breakthrough for years. This article weighs the possibility that could this hydrogen st...
A clear, actionable look at beyond (xair) 2026 earnings and what a Q4 earnings call could reveal. Learn how to read t...
Owning two cash-flowing rentals often triggers a financing blockade. This guide explains why the trap: traditional fi...
Investors often wonder if a smaller company can replicate Berkshire Hathaway’s long-term success. This analysis looks...
What would it take for Micron Technology stock to run from here to a life-changing level in a year? This article lays...